tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CNTA Stock Latest News

Morgan Stanley upgrades Centessa on ‘best-in-class’ potential of ORX750
The FlyMorgan Stanley upgrades Centessa on ‘best-in-class’ potential of ORX750
10h ago
CNTA
Centessa upgraded to Overweight from Equal Weight at Morgan Stanley
PremiumThe Fly
Centessa upgraded to Overweight from Equal Weight at Morgan Stanley
10h ago
CNTA
Centessa initiated with a Buy at B. Riley
PremiumThe Fly
Centessa initiated with a Buy at B. Riley
21h ago
CNTA
Centessa initiated with a Buy at B. Riley
PremiumThe Fly
Centessa initiated with a Buy at B. Riley
1d ago
CNTA
Centessa price target raised to $35 from $20 at BMO Capital
PremiumThe Fly
Centessa price target raised to $35 from $20 at BMO Capital
4d ago
CNTA
Centessa 15.25M share Spot Secondary priced at $14.75
PremiumThe FlyCentessa 15.25M share Spot Secondary priced at $14.75
7d ago
CNTA
Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares
Premium
Press Releases
Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares
7d ago
CNTA
Centessa announces $150M American Depositary Shares offering
Premium
The Fly
Centessa announces $150M American Depositary Shares offering
8d ago
CNTA
Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares
PremiumPress Releases
Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares
8d ago
CNTA
Centessa files automatic mixed securities shelf
PremiumThe Fly
Centessa files automatic mixed securities shelf
8d ago
CNTA
Centessa price target raised to $19 from $13 at Jefferies
PremiumThe Fly
Centessa price target raised to $19 from $13 at Jefferies
9d ago
CNTA
Centessa price target raised to $24 from $20 at Guggenheim
PremiumThe Fly
Centessa price target raised to $24 from $20 at Guggenheim
9d ago
CNTA
Centessa price target raised to $22 from $14 at Leerink
PremiumThe FlyCentessa price target raised to $22 from $14 at Leerink
9d ago
CNTA
Mizuho says hard to tell yet how Centessa and Alkermes stack up in narcolepsy
Premium
The Fly
Mizuho says hard to tell yet how Centessa and Alkermes stack up in narcolepsy
10d ago
ALKS
CNTA
Oracle reports Q1 beat, EU says Apple must pay: Morning Buzz
Premium
The Fly
Oracle reports Q1 beat, EU says Apple must pay: Morning Buzz
10d ago
C
GS
Centessa Pharmaceuticals Advances Sleep Disorder Drug Trials
PremiumCompany Announcements
Centessa Pharmaceuticals Advances Sleep Disorder Drug Trials
10d ago
8K
CNTA
Centessa announces interim data from ongoing Phase 1 trial of ORX750
PremiumThe Fly
Centessa announces interim data from ongoing Phase 1 trial of ORX750
10d ago
CNTA
Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers
PremiumPress Releases
Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers
10d ago
CNTA
Centessa price target raised to $20 from $15 at BMO Capital
PremiumThe Fly
Centessa price target raised to $20 from $15 at BMO Capital
11d ago
CNTA
Centessa to present non-human primate data for ORX142 at Sleep Europe 2024
PremiumThe FlyCentessa to present non-human primate data for ORX142 at Sleep Europe 2024
24d ago
CNTA
Centessa Pharmaceuticals Announces Late-Breaking Poster Presentation of Non-Human Primate Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024)
Premium
Press Releases
Centessa Pharmaceuticals Announces Late-Breaking Poster Presentation of Non-Human Primate Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024)
24d ago
CNTA
Centessa Pharmaceuticals to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Premium
Press Releases
Centessa Pharmaceuticals to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
30d ago
CNTA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >